Biotech News
Newleos Therapeutics Appoints Timothy Noyes as President and CEO
Newleos Therapeutics, a clinical-stage biotechnology company developing treatments for neuropsychiatric disorders, has named Timothy Noyes as its new President and Chief Executive Officer. Mr. Noyes succeeds founding CEO David Donabedian, who will remain with the company in an advisory role.
22 October 2025